Jury Reaches Defense Verdict for J&J at Conclusion of Bifurcated Talcum Powder Trial



DOCUMENTS
  • Verdict Sheet


PHILADELPHIA –– Jurors have reached a defense verdict in favor of Johnson & Johnson and Johnson & Johnson Consumer Inc. at the conclusion of a bifurcated talcum powder trial, rejecting the plaintiff’s claims that she developed ovarian cancer as a result of using the defendants’ talcum powder products.

The Pennsylvania Court of Common Pleas for Philadelphia County jury reached the verdict just moments ago, completing a trial that kicked off on Aug. 18.

According to the verdict sheet, jurors found that the plaintiffs had not proven by a preponderance of the evidence that Johnson & Johnson’s Baby Powder was a …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS